GlaxoSmithKline PLC Director/PDMR Shareholding (1361K)
April 14 2015 - 4:35AM
UK Regulatory
TIDMGSK
RNS Number : 1361K
GlaxoSmithKline PLC
14 April 2015
GlaxoSmithKline plc
Notification of Transactions of Directors, Persons
Discharging
Managerial Responsibility or Connected Persons
In accordance with DTR 3.1.4R(1)(a) GlaxoSmithKline plc ('GSK')
was advised on 13 April 2015, of changes in the interests of the
following Directors and Persons Discharging Managerial
Responsibility, following increases in their notional interests in
Ordinary Shares and American Depositary Shares (ADSs), at a price
of 1591.00 pence per Ordinary Share and $47.41 per ADS, following
the re-investment of dividends paid on Ordinary Shares and ADSs
held in the GlaxoSmithKline 2009 Deferred Annual Bonus Plan.
Director/PDMR Number of Ordinary Number of Ordinary
Shares acquired Shares acquired
under the personal under the matching
contribution element of
element of the the plan
plan (GSK contribution)
--------------------- --------------------- ---------------------
Sir Andrew Witty 1,803 1,803
--------------------- --------------------- ---------------------
Mr S Dingemans 687 687
--------------------- --------------------- ---------------------
Mr R G Connor 358 358
--------------------- --------------------- ---------------------
Mr N Hirons 77 77
--------------------- --------------------- ---------------------
Mr S A Hussain 307 307
--------------------- --------------------- ---------------------
Mr D S Redfern 384 384
--------------------- --------------------- ---------------------
Ms C Thomas 264 264
--------------------- --------------------- ---------------------
Mr P C Thomson 129 129
--------------------- --------------------- ---------------------
Dr P J T Vallance 922 922
--------------------- --------------------- ---------------------
Ms E Walmsley 542 542
--------------------- --------------------- ---------------------
Director/PDMR Number of ADSs Number of ADSs
acquired under acquired under
the personal the matching
contribution element of
element of the the plan
plan (GSK contribution)
----------------- ----------------- ---------------------
Dr M M Slaoui 713 713
----------------- ----------------- ---------------------
Mr W C Louv 183 183
----------------- ----------------- ---------------------
Mr D E Troy 301 301
----------------- ----------------- ---------------------
V A Whyte
Company Secretary
14 April 2015
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSVZLBFEZFXBBF
Gsk (LSE:GSK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2023 to Apr 2024